Table of Content

1 Report Overview
1.1 T Cell Specific Surface Glycoprotein CD28 Definition
1.2 Market by Type
1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 FPT-155
1.2.3 FR-104
1.2.4 Lulizumab Pegol
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Plaque Psoriasis
1.3.3 Solid Tumor
1.3.4 Acute Renal Failure(ARF)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global T Cell Specific Surface Glycoprotein CD28 Sales
2.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue Estimates and Forecasts 2018-2034
2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region
2.3.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2018-2023)
2.3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2024-2034)
2.4 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region
2.6.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region (2018-2023)
2.6.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Manufacturers
3.1.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by T Cell Specific Surface Glycoprotein CD28 Sales in 2024
3.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers
3.2.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers (2018-2023)
3.2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by T Cell Specific Surface Glycoprotein CD28 Revenue in 2024
3.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Price by Manufacturers
3.4 Global Key Players of T Cell Specific Surface Glycoprotein CD28, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global T Cell Specific Surface Glycoprotein CD28 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of T Cell Specific Surface Glycoprotein CD28, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of T Cell Specific Surface Glycoprotein CD28, Product Offered and Application
3.8 Global Key Manufacturers of T Cell Specific Surface Glycoprotein CD28, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type
4.1.1 Global T Cell Specific Surface Glycoprotein CD28 Historical Sales Quantity by Type (2018-2023)
4.1.2 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
4.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type
4.2.1 Global T Cell Specific Surface Glycoprotein CD28 Historical Revenue by Type (2018-2023)
4.2.2 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Revenue by Type (2024-2034)
4.2.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
4.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Type
4.3.1 Global T Cell Specific Surface Glycoprotein CD28 Price by Type (2018-2023)
4.3.2 Global T Cell Specific Surface Glycoprotein CD28 Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application
5.1.1 Global T Cell Specific Surface Glycoprotein CD28 Historical Sales Quantity by Application (2018-2023)
5.1.2 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
5.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application
5.2.1 Global T Cell Specific Surface Glycoprotein CD28 Historical Revenue by Application (2018-2023)
5.2.2 Global T Cell Specific Surface Glycoprotein CD28 Forecasted Revenue by Application (2024-2034)
5.2.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
5.3 Global T Cell Specific Surface Glycoprotein CD28 Price by Application
5.3.1 Global T Cell Specific Surface Glycoprotein CD28 Price by Application (2018-2023)
5.3.2 Global T Cell Specific Surface Glycoprotein CD28 Price Forecast by Application (2024-2034)
6 North America
6.1 North America T Cell Specific Surface Glycoprotein CD28 Sales by Company
6.1.1 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023)
6.1.2 North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023)
6.2 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Type
6.2.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2034)
6.2.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2034)
6.3 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Application
6.3.1 North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2034)
6.3.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2034)
6.4 North America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
6.4.1 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2018-2034)
6.4.3 North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales by Company
7.1.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023)
7.1.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023)
7.2 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Type
7.2.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2034)
7.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2034)
7.3 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Application
7.3.1 Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2034)
7.3.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2034)
7.4 Europe T Cell Specific Surface Glycoprotein CD28 Market Size by Country
7.4.1 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2018-2034)
7.4.3 Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China T Cell Specific Surface Glycoprotein CD28 Sales by Company
8.1.1 China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023)
8.1.2 China T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023)
8.2 China T Cell Specific Surface Glycoprotein CD28 Market Size by Type
8.2.1 China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2034)
8.2.2 China T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2034)
8.3 China T Cell Specific Surface Glycoprotein CD28 Market Size by Application
8.3.1 China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2034)
8.3.2 China T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales by Company
9.1.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023)
9.1.2 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023)
9.2 APAC T Cell Specific Surface Glycoprotein CD28 Market Size by Type
9.2.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2034)
9.2.2 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2034)
9.3 APAC T Cell Specific Surface Glycoprotein CD28 Market Size by Application
9.3.1 APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2034)
9.3.2 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2034)
9.4 APAC T Cell Specific Surface Glycoprotein CD28 Market Size by Region
9.4.1 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2018-2034)
9.4.3 APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales by Company
10.1.1 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Market Size by Type
10.2.1 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Market Size by Application
10.3.1 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Market Size by Country
10.4.1 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Atox Bio Ltd
11.1.1 Atox Bio Ltd Company Information
11.1.2 Atox Bio Ltd Overview
11.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Products and Services
11.1.5 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
11.1.6 Atox Bio Ltd Recent Developments
11.2 Bristol-Myers Squibb Co
11.2.1 Bristol-Myers Squibb Co Company Information
11.2.2 Bristol-Myers Squibb Co Overview
11.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Products and Services
11.2.5 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
11.2.6 Bristol-Myers Squibb Co Recent Developments
11.3 Five Prime Therapeutics Inc
11.3.1 Five Prime Therapeutics Inc Company Information
11.3.2 Five Prime Therapeutics Inc Overview
11.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Products and Services
11.3.5 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
11.3.6 Five Prime Therapeutics Inc Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Products and Services
11.4.5 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
11.4.6 Johnson & Johnson Recent Developments
11.5 TheraMAB LLC
11.5.1 TheraMAB LLC Company Information
11.5.2 TheraMAB LLC Overview
11.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Products and Services
11.5.5 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
11.5.6 TheraMAB LLC Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 T Cell Specific Surface Glycoprotein CD28 Value Chain Analysis
12.2 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 T Cell Specific Surface Glycoprotein CD28 Production Mode & Process
12.4 T Cell Specific Surface Glycoprotein CD28 Sales and Marketing
12.4.1 T Cell Specific Surface Glycoprotein CD28 Sales Channels
12.4.2 T Cell Specific Surface Glycoprotein CD28 Distributors
12.5 T Cell Specific Surface Glycoprotein CD28 Customers
13 Market Dynamics
13.1 T Cell Specific Surface Glycoprotein CD28 Industry Trends
13.2 T Cell Specific Surface Glycoprotein CD28 Market Drivers
13.3 T Cell Specific Surface Glycoprotein CD28 Market Challenges
13.4 T Cell Specific Surface Glycoprotein CD28 Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of FPT-155
Table 3. Major Manufacturers of FR-104
Table 4. Major Manufacturers of Lulizumab Pegol
Table 5. Major Manufacturers of Others
Table 6. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2018-2023)
Table 10. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2024-2034)
Table 12. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 13. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2018-2023) & (K Pcs)
Table 14. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2018-2023)
Table 15. Global T Cell Specific Surface Glycoprotein CD28 Sales by Region (2024-2034) & (K Pcs)
Table 16. Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region (2024-2034)
Table 17. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 18. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Manufacturers (2018-2023)
Table 19. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Manufacturers (2018-2023)
Table 21. Global T Cell Specific Surface Glycoprotein CD28 Price by Manufacturers 2018-2023 (USD/Pcs)
Table 22. Global Key Players of T Cell Specific Surface Glycoprotein CD28, Industry Ranking, 2021 VS 2024
Table 23. Global T Cell Specific Surface Glycoprotein CD28 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global T Cell Specific Surface Glycoprotein CD28 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Specific Surface Glycoprotein CD28 as of 2024)
Table 25. Global Key Manufacturers of T Cell Specific Surface Glycoprotein CD28, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of T Cell Specific Surface Glycoprotein CD28, Product Offered and Application
Table 27. Global Key Manufacturers of T Cell Specific Surface Glycoprotein CD28, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 30. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Type (2018-2023)
Table 32. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Type (2024-2034)
Table 33. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2018-2023)
Table 36. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2024-2034)
Table 37. T Cell Specific Surface Glycoprotein CD28 Price by Type (2018-2023) & (USD/Pcs)
Table 38. Global T Cell Specific Surface Glycoprotein CD28 Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 40. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Application (2018-2023)
Table 42. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Application (2024-2034)
Table 43. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2018-2023)
Table 46. Global T Cell Specific Surface Glycoprotein CD28 Revenue Share by Application (2024-2034)
Table 47. T Cell Specific Surface Glycoprotein CD28 Price by Application (2018-2023) & (USD/Pcs)
Table 48. Global T Cell Specific Surface Glycoprotein CD28 Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023) & (US$ Million)
Table 50. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 51. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 52. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2023) & (US$ Million)
Table 54. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 56. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2023) & (US$ Million)
Table 58. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 60. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2018-2023) & (US$ Million)
Table 61. North America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 63. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 65. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023) & (US$ Million)
Table 66. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 67. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 71. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 75. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 78. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 80. China T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023) & (US$ Million)
Table 81. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 82. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2023) & (US$ Million)
Table 84. China T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2024-2034) & (US$ Million)
Table 85. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 86. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2023) & (US$ Million)
Table 88. China T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 90. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023) & (US$ Million)
Table 91. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 92. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2023) & (US$ Million)
Table 94. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 96. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2023) & (US$ Million)
Table 98. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 100. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2018-2023) & (US$ Million)
Table 101. APAC T Cell Specific Surface Glycoprotein CD28 Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region (2018-2023) & (K Pcs)
Table 103. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Company (2018-2023) & (K Pcs)
Table 105. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Company (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2018-2023) & (US$ Million)
Table 109. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2018-2023) & (K Pcs)
Table 111. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2018-2023) & (US$ Million)
Table 113. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2018-2023) & (US$ Million)
Table 116. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2018-2023) & (K Pcs)
Table 118. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Atox Bio Ltd Company Information
Table 120. Atox Bio Ltd Description and Overview
Table 121. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 122. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 123. Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
Table 124. Atox Bio Ltd Recent Developments
Table 125. Bristol-Myers Squibb Co Company Information
Table 126. Bristol-Myers Squibb Co Description and Overview
Table 127. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 129. Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
Table 130. Bristol-Myers Squibb Co Recent Developments
Table 131. Five Prime Therapeutics Inc Company Information
Table 132. Five Prime Therapeutics Inc Description and Overview
Table 133. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 134. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 135. Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
Table 136. Five Prime Therapeutics Inc Recent Developments
Table 137. Johnson & Johnson Company Information
Table 138. Johnson & Johnson Description and Overview
Table 139. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 140. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 141. Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
Table 142. Johnson & Johnson Recent Developments
Table 143. TheraMAB LLC Company Information
Table 144. TheraMAB LLC Description and Overview
Table 145. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 146. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Product and Services
Table 147. TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 SWOT Analysis
Table 148. TheraMAB LLC Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. T Cell Specific Surface Glycoprotein CD28 Distributors List
Table 152. T Cell Specific Surface Glycoprotein CD28 Customers List
Table 153. T Cell Specific Surface Glycoprotein CD28 Market Trends
Table 154. T Cell Specific Surface Glycoprotein CD28 Market Drivers
Table 155. T Cell Specific Surface Glycoprotein CD28 Market Challenges
Table 156. T Cell Specific Surface Glycoprotein CD28 Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Specific Surface Glycoprotein CD28 Product Picture
Figure 2. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global T Cell Specific Surface Glycoprotein CD28 Market Share by Type in 2024 & 2034
Figure 4. FPT-155 Product Picture
Figure 5. FR-104 Product Picture
Figure 6. Lulizumab Pegol Product Picture
Figure 7. Others Product Picture
Figure 8. Global T Cell Specific Surface Glycoprotein CD28 Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 9. Global T Cell Specific Surface Glycoprotein CD28 Market Share by Application in 2024 & 2034
Figure 10. Plaque Psoriasis
Figure 11. Solid Tumor
Figure 12. Acute Renal Failure(ARF)
Figure 13. Others
Figure 14. T Cell Specific Surface Glycoprotein CD28 Report Years Considered
Figure 15. Global T Cell Specific Surface Glycoprotein CD28 Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global T Cell Specific Surface Glycoprotein CD28 Revenue 2018-2034 (US$ Million)
Figure 17. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America T Cell Specific Surface Glycoprotein CD28 Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe T Cell Specific Surface Glycoprotein CD28 Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China T Cell Specific Surface Glycoprotein CD28 Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC T Cell Specific Surface Glycoprotein CD28 Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by T Cell Specific Surface Glycoprotein CD28 Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by T Cell Specific Surface Glycoprotein CD28 Revenue in 2024
Figure 33. T Cell Specific Surface Glycoprotein CD28 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
Figure 36. Global T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
Figure 38. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2024
Figure 39. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Company in 2024
Figure 40. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
Figure 42. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
Figure 44. North America T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2018-2034)
Figure 45. North America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 47. Canada T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 48. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Company in 2024
Figure 49. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2024
Figure 50. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
Figure 52. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
Figure 54. Europe T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2018-2034)
Figure 55. Europe T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Country (2018-2034)
Figure 56. Germany T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 57. France T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 59. Italy T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 60. Russia T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 61. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Company in 2024
Figure 62. China T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2024
Figure 63. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
Figure 64. China T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
Figure 65. China T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
Figure 66. China T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
Figure 67. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Company in 2024
Figure 68. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2024
Figure 69. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
Figure 71. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
Figure 73. APAC T Cell Specific Surface Glycoprotein CD28 Revenue Share by Region (2018-2034)
Figure 74. APAC T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Region (2018-2034)
Figure 75. Japan T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 79. India T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America T Cell Specific Surface Glycoprotein CD28 Revenue Share by Country (2018-2034)
Figure 88. Brazil T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 91. Israel T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries T Cell Specific Surface Glycoprotein CD28 Revenue (2018-2034) & (US$ Million)
Figure 93. T Cell Specific Surface Glycoprotein CD28 Value Chain
Figure 94. T Cell Specific Surface Glycoprotein CD28 Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed